OBCK Ottobock SE & Co. KGaA

XETRA · DE · Healthcare · Medical Instruments & Supplies · corporate.ottobock.com

51.00EUR+1.59%Mkt Cap: 3.55B $P/E: 25.12Today

Ottobock SE & Co. KGaA develops, produces, and distributes medical technology products and components for the people with disabilities in the fields of prosthetics, orthotics, human mobility, and industrial exoskeletons …

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$142.99BUSDP/E 46.4

EssilorLuxottica Société anonyme

$73.15BUSDP/E 27.4

BDX

Becton, Dickinson and Company

West Pharmaceutical Services, Inc.

$26.22BUSDP/E 47.7

DIM

Sartorius Stedim Biotech S.A.

$22.82BUSDP/E 71.7

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.50BUSDP/E 73.0

SOLV

Solventum Corporation

$14.82BUSDP/E 10.7

BAX

Baxter International Inc.

$12.59BUSD

COO

The Cooper Companies, Inc.

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap3.55B USD

Enterprise Value4.84B USD

Revenue (TTM)1.88B USD

Gross Profit963.59M USD

Net Income (TTM)98.04M USD

Revenue/Share27.29 EUR

Last Price51.00 EUR

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees9.4K

CountryDE

SectorHealthcare

IndustryMedical Instruments & Supplies

ISINDE000BCK2223

Valuation

P/E (Trailing)25.12

P/E (Forward)14.00

PEG—

EV/EBITDA13.13

EV/Revenue2.57

P/S1.88

P/B8.21

EPS (TTM)2.01

EPS (Forward)3.63

52W Range

45.5618% of range76.35

52W High76.35 EUR

52W Low45.56 EUR

Profitability

Gross Margin52.77%

Oper. Margin18.42%

EBITDA Margin19.57%

Profit Margin5.37%

ROE23.12%

ROA4.40%

Growth

Revenue Growth9.60%

Earnings Growth306.80%

Cash Flow & Leverage

Operating CF362.17M USD

CapEx (TTM)118.15M USD

FCF Margin5.80%

FCF Yield3.08%

Net Debt1.30B USD

Net Debt/EBITDA3.53

Balance Sheet

Debt/Equity2.69

Current Ratio1.23

Quick Ratio0.64

Book Value/Sh6.19 EUR

Cash/Share1.46 EUR

Dividends

Fwd Div Rate0.97 EUR

Trail. Div Rate0.97 EUR

Div. Yield1.91%

5Y Avg Yield—

Payout Ratio48.26%

Ex-Div DateMay 20, 2026

Pay Date—

Analyst Consensus

Rating—

Target (Mean)80.38 EUR

Upside (mean)+57.6%

Target Range66.00 EUR – 88.00 EUR

66.00+57.6% to mean88.00

# Analysts8

Ownership

Shares Out.63.99M

Float9.01M

Insiders82.44%

Institutions11.77%

Technical

SMA 5056.95 (-10.5%)

SMA 20055.77 (-8.6%)

Beta—

S&P 52W Chg14.58%

Avg Vol (30d)10.66K

Avg Vol (10d)9.21K

Technical Indicators

RSI (14)29.9

MACD-1.5804

MACD Signal-1.1455

MACD Hist.-0.4349

BB Upper57.93 EUR

BB Middle54.19 EUR

BB Lower50.46 EUR

BB Width13.79%

ATR (14)1.616 EUR

Vol Ratio (20d)2.70x